CJC-1295 (No DAC) + Ipamorelin: Peptide Profile
Sequence, molecular data, research status and testing standards for CJC-1295 (No DAC) + Ipamorelin — written for Canadian researchers.
What Is CJC-1295 (No DAC) + Ipamorelin?
A lyophilized blend of CJC-1295 without DAC (Modified GRF 1-29), a GHRH analogue, and Ipamorelin, a selective pentapeptide ghrelin-receptor agonist, supplied for endocrine research.
What the Research Says About CJC-1295 (No DAC) + Ipamorelin
Modified GRF (1-29) is a stabilized analogue of growth hormone-releasing hormone, and ipamorelin is a selective ghrelin-receptor (GHS-R) agonist. Both have been studied in endocrine research on pulsatile growth hormone release. Neither is authorized by Health Canada.
Peptide Authority summarizes published research for educational purposes only. Nothing here is medical advice or a claim that CJC-1295 (No DAC) + Ipamorelin is safe or effective for any use.
CJC-1295 (No DAC) + Ipamorelin Storage & Handling
Lyophilized (freeze-dried) CJC-1295 (No DAC) + Ipamorelin is most stable frozen at −20°C or colder for long-term storage, or refrigerated at 2–8°C for short periods. Keep vials sealed, dry and away from light, and allow them to reach room temperature before opening to prevent condensation.
What to Look for in a CJC-1295 (No DAC) + Ipamorelin Certificate of Analysis
- HPLC purity of 98–99% or higher, shown as a chromatogram with one dominant peak
- Mass spectrometry with an observed mass matching 3367.9 / 711.9 g/mol
- A lot number that matches the label on your vial
- An independent, named laboratory and a recent test date
Learn more in our guide to peptide lab testing and COAs.
Is CJC-1295 (No DAC) + Ipamorelin Legal in Canada?
CJC-1295 (No DAC) + Ipamorelin is not authorized by Health Canada as a drug. It may only be sold in Canada as a research chemical for in-vitro laboratory use — not for human or animal consumption. Read how peptides are regulated in Canada.
CJC-1295 (No DAC) + Ipamorelin FAQs
What is CJC-1295 (No DAC) + Ipamorelin?
A lyophilized blend of CJC-1295 without DAC (Modified GRF 1-29), a GHRH analogue, and Ipamorelin, a selective pentapeptide ghrelin-receptor agonist, supplied for endocrine research. It is also known as Mod GRF 1-29; Ipamorelin (NNC 26-0161).
Is CJC-1295 (No DAC) + Ipamorelin legal in Canada?
CJC-1295 (No DAC) + Ipamorelin is not authorized by Health Canada as a drug, so it cannot legally be sold for human or animal use. In Canada it is sold as a research chemical for in-vitro laboratory use only. This is general information, not legal advice.
Where can I buy CJC-1295 (No DAC) + Ipamorelin in Canada?
Peptide Authority supplies HPLC-tested, lot-coded CJC-1295 (No DAC) + Ipamorelin for research use, now serving Edmonton with Canada-wide shipping coming soon. Wherever you buy, insist on a third-party COA that matches the lot number on your vial.
How should CJC-1295 (No DAC) + Ipamorelin be stored?
Store lyophilized CJC-1295 (No DAC) + Ipamorelin frozen at −20°C for long-term stability or refrigerated at 2–8°C short-term, protected from light and moisture.
Is CJC-1295 (No DAC) + Ipamorelin banned in sport?
Yes. CJC-1295 (No DAC) + Ipamorelin is on the World Anti-Doping Agency (WADA) Prohibited List: Prohibited — S2 (GHRH analogues and GH secretagogues).
Related Peptide Profiles
Educational Content & Research Use Only
This profile is for information only and is not medical advice. Products sold by Peptide Authority are for in-vitro laboratory research only and are not for human or animal consumption. See our full disclaimer.